Gapping up
In reaction to strong earnings/guidance: NFLX +19%, TACO +8.9%, CXW +5.3%, (ICE amends with lower fixed payment and extends contract at the South Texas Family Residential Center; guides Q3 FFO in-line, FY16 light with FY17 above estimates),TTS +4.5%, CE +3.8%, (also announced to acquire Italy based SO.F.TER; terms not disclosed), MTG +3%, DPZ +2.8%, PACW+2.3%, RYAAY +2.2%, UNH +2%, GIG +1.5%, GS +1.3%, PM +1.1%, BLK +1%
M&A news: SM +5.8% (Sold drilling assets to OAS)
Select financial related names showing strength: IBN +4.9%, RBS +4%, BCS +3.4%, BBVA +2.7%, HSBC +2.6%
Select metals/mining stocks trading higher: DRD +4.1%, GFI +3.6%, BBL +3.4%, BHP +3%, AG +2.9%, PAAS +2.8%,GOLD +2.6%, VALE +2.5%, AUY +2.2%, FCX +2%, ABX +1.9%, MT +1.9%, AU +1.8%, GDX +1.7%, SLW +1.5%
Select oil/gas related names showing strength: SDRL +3.5%, RIG +2.1%, BT +1.9%, BP +1.7%
Other news:
In reaction to strong earnings/guidance: NFLX +19%, TACO +8.9%, CXW +5.3%, (ICE amends with lower fixed payment and extends contract at the South Texas Family Residential Center; guides Q3 FFO in-line, FY16 light with FY17 above estimates),TTS +4.5%, CE +3.8%, (also announced to acquire Italy based SO.F.TER; terms not disclosed), MTG +3%, DPZ +2.8%, PACW+2.3%, RYAAY +2.2%, UNH +2%, GIG +1.5%, GS +1.3%, PM +1.1%, BLK +1%
M&A news: SM +5.8% (Sold drilling assets to OAS)
Select financial related names showing strength: IBN +4.9%, RBS +4%, BCS +3.4%, BBVA +2.7%, HSBC +2.6%
Select metals/mining stocks trading higher: DRD +4.1%, GFI +3.6%, BBL +3.4%, BHP +3%, AG +2.9%, PAAS +2.8%,GOLD +2.6%, VALE +2.5%, AUY +2.2%, FCX +2%, ABX +1.9%, MT +1.9%, AU +1.8%, GDX +1.7%, SLW +1.5%
Select oil/gas related names showing strength: SDRL +3.5%, RIG +2.1%, BT +1.9%, BP +1.7%
Other news:
- TWMC +14.7% (thinly traded - Trans World to acquire digital marketplace retail company etailz for approx $75 mln in cash and stock; to be accretive in first full fiscal year)
- RECN +8.3% (intends to commence a modified 'Dutch auction' tender offer to purchase up to approximately 6 mln shares of its common stock at a price per share not greater than $16.00 nor less than $13.50 )
- CRBP +7.2% (EC has granted Orphan Designation in the EU for its Resunab for the treatment of cystic fibrosis -- data expected in early 2017)
- MDCO +6.1% (announces top-line results from the interim analysis with Day 90 follow-up for all 501 patients enrolled in the ongoing Orion-1 study of PCSK9si)
- ATNM +5.1% (announces that its lead asset, Iomab-B, has been granted orphan designation in the EU by the EMA)
- SPLS +2.6% (Staples higher in after hours following UK Telegraph story suggesting Cerberus may purchase its UK retail stores)
- AZN +2.2% (receives acceptance from the FDA for NDA re-submission for sodium zirconium cyclosilicate)
- SHPG +1.8% (receives Marketing Authorization for Onivyde in EU)
- DEPO +1.6% (DepoMed and Starboard announce settlement agreement; Depomed Board to include three new independent directors, Starboard to withdraw request for Special Meeting)
- GEO +1.3% (CXW sympathy)
- JD +1.3% (Shanghai closed +1.4% overnight)
- SCTY +1.2% ( has created a new fund to finance more than $300 mln in solar projects with Credit Suisse)
- AMZN +1.1% (higher with NFLX/tech names; also announced Cloud now available to customers from data centers in Ohio)
- SEE +1% (Sealed Air to pursue spin-off of Diversey Care and related hygiene business; reached a mutual agreement to end the existing business relating to Sealed Air's distribution of SCJ branded products)
Analyst comments:
- SRPT +3.1% (initiated with a Outperform at Credit Suisse)
- TS +2.7% (upgraded to Overweight from Neutral at Piper Jaffray)
- GSUM +2% (initiated with a Buy at Goldman)
- INTC +1.4% (upgraded to Overweight from Equal Weight at Barclay )
- CRM +1.4% (initiated with a Buy at Rosenblatt)
- PKG +1.3% (upgraded to Buy from Neutral at BofA/Merrill)
- VVV +0.9% (initiated with a Buy at Citigroup; initiated with a Buy at BofA/Merrill)